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Abstract: A state-of-the-art review of a widely-
used health promotion technique, the health hazard/
health risk appraisal (HHA/HRA), was conducted.
The review included preparing a 212-item annotated
bibliography, compiling an inventory of 217 programs
that have used HHA/HRA, holding discussions with
HHA/HRA developers and users, conducting formal
site visits to 15 HHA/HRA programs, and consultation
with experts in epidemiology, biostatistics, and behav-
ioral science as well as developers and users of HHA/
HRA.
Programs use HHA/HRA primarily as a promo-
tional device, as a tool for structuring education about
Introduction
Health Hazard/Health Risk Appraisal (HHA/HRA) is a
health promotion technique in which an individual's health-
related behaviors and personal characteristics are compared
to mortality statistics and epidemiologic data' 2 in order to
estimate his or her risk of dying by some specified future
time along with the amount of that risk which could be
eliminated by making appropriate behavioral changes. These
measurements of risk and the potential benefits of behavioral
changes are presented to the individual in order to stimulate
his/her participation in activities aimed at changing life-style
and improving health.
This technique has been widely adopted in recent years
for a variety of reasons. First, it provides the health educator
with a rationale and teaching aid to focus discussions of
health and behavior. Second, it relies on self-administered
questionnaires, simple physiologic measurements, and com-
puter-assisted calculations, making its application to large
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health-related behaviors, and as a motivational device
for stimulating behavioral change. The scientific basis
for HHA/HRA risk predictions is problematic, but
their arithmetic imprecision is of less concern than
insufficiency of the scientific evidence for certain
behavioral recommendations, and inaccuracies in cli-
ent-supplied data. Widely-held beliefs in HHA/HRA's
efficacy for motivating behavioral change cannot be
substantiated from available evidence, nor can the
assumed absence of adverse effects. The importance
of this particular health promotion technique appears
to have been exaggerated. (Am J Public Health 1982;
72:347-352.)
groups feasible, efficient, and relatively inexpensive. Third,
it has all the trappings of modern science with reference to
studies, precise numbers, and computer printed reports and
is, therefore, consistent with the established values of many
segments of American society. Fourth, it is consonant with
current thinking and publicity about the role of life-style in
disease etiology. Fifth, the data gathering devices, computer
software, and other aspects of the program can be marketed
as a package which has stimulated the involvement of
commercial firms. Thus, there are strong cultural, political,
and economic pressures for wider application of such an
approach. The recent entry of large commercial firms into
the marketing of HHA/HRA packages provides further
evidence of the growing popularity and enthusiasm for this
strategy.
Because of this increasing interest in HHA/HRA, it is
timely to assess the contribution that HHA/HRA has made
(or can make) to health promotion/disease prevention (HP/
DP). In this atmosphere of enthusiasm, burgeoning use, yet
lingering concerns, we have attempted to document the
extent and manner in which HHA/HRA is being applied, as
well as to review its scientific basis, efficacy, and effective-
ness, through literature review, consultation, and the study
of a limited number of currently operational programs.
More specifically, we sought some answers to the
following questions:
1. How sound is the scientific basis for the assessment
of individual risk and benefits of appropriate behavioral
change?
2. How do programs measure individual health charac-
teristics and to what extent do problems in measurement
influence the acceptability and utility of HHA/HRA?
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3. How do programs compute risk and to what extent do
various HHA/HRA approaches yield different risk and bene-
fit assessments for clients with similar characteristics?
4. What are the settings in which HHA/HRA is being
used and to what extent do the characteristics of the setting
influence the success or failure of HHA/HRA?
5. What is the evidence supporting a positive effect of
HHA/HRA on participation, knowledge, health-related be-
haviors, and morbidity and mortality?
6. What is the evidence of physical/psychological risk
associated with HHAIHRA?
7. What is the acceptability, validity, and efficacy of
HHA/HRA for less-advantaged social groups?
8. What are the major areas regarding HHA/HRA that
are in need of further research?
Although many more questions were addressed, we
consider these questions to be fundamental. This paper
summarizes our approach to the questions and our best
response to each.
Methods
Multiple approaches to information-gathering and re-
view characterize the methods used. These include:
* literature review;
* compilation and review of an inventory of HHA/HRA
instruments and programs;
* consultation with experts in epidemiology, biostatis-
tics, and behavioral science as well as developers and users
of HHA/HRA;
* epidemiologic and biostatistical review of risk estima-
tion in HHA/HRA; and
* site visits to HHA/HRA programs.
Literature Review
Through formal library sources and personal communi-
cations, we attempted to identify and obtain all published
and unpublished documents pertaining to HHA/HRA or
related issues in HP/DP. Two hundred twelve books, arti-
cles, reports, theses, and speeches were critically reviewed
and annotated.3
Inventory of HHA/HRA Instruments and Programs
We attempted to identify and catalogue HHA/HRA
instruments and programs in the following manner. First, all
extant suppliers of instruments or services, both public and
private, were contacted and requested to supply us with
sample instruments and a list of active clients. All responded
with sample instruments and with a list of clients which
varied considerably in size and, we think, in completeness.
These lists were supplemented with programs known to us
through the literature review and personal contacts. By
these means, 217 programs were identified and contacted by
letter and occasionally by telephone. Each program was
asked for the following information: location, sponsorship,
HHA/HRA instrument used, year of program initiation,
number of HHA/HRAs performed, important client groups,
risk reduction services provided, fee charged for HHAI
HRA, and availability of evaluation data.4
Expert Panel
In an effort to obtain continuing input from individuals
knowledgeable in various issues of importance to the assess-
ment of HHA/HRA, a panel was convened consisting of
experts in the fields of epidemiology, biostatistics, health
education, communications, cost-benefit analysis, and
health policy. Each member of the panel was interviewed
individually and participated in a two-day conference. The
input of the expert panel was supplemented by additional
consultations with important figures in the development of
HHA/HRA as well as other authorities in health education,
epidemiology, and biostatistics.
Epidemiologic and Biostatistical Review
In consultation with relevant members of the expert
panel and others, we systematically reviewed the content of
HHA/HRA data-gathering instruments, the health character-
istics considered in HHA/HRA programs, and the major
epidemiologic studies from which HHA/HRA developers
derived the statistics upon which HHA/HRA depends. Our
review included relevant biometric literature and simulation
of HHA/HRA results for hypothetical clients.5
Site Visits
From the inventory of known HHA/HRA programs, 15
programs were visited by a team consisting of two or three
members. In order to emphasize stable and substantive
programs, we generally restricted our purview to programs
which had administered at least 300 HHA/HRAs in the
previous year. Exceptions were made for programs using
innovative approaches, conducting major evaluations, or
serving minority or low-income clients. These were given
priority for site visits. The programs we visited, in the
aggregate, used a full range of available HHA/HRA instru-
ments in a variety of settings, with a broad range of risk
reduction services. Site visits were conducted over a one- to
two-day period using a structured protocol. We interviewed
both program staff and managers in the sponsoring institu-
tion(s) responsible for the program's current and future
position within the institution.
Results and Discussion
1. How sound is the scientific basis for the assessment
of individual risk and benefits of appropriate behavioral
changes?
HHA/HRA begins with the measurement, mostly by
self-report questionnaire, of the client's behaviors and per-
sonal characteristics (e.g., smoking habits, alcohol intake,
family history of cancer and heart disease, amount of
exercise, frequency of physical check-ups for Pap smears,
and breast examinations) viewed as predictive of an in-
creased or decreased chance of dying from one of the leading
causes of death. Each client response is assigned a numerical
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value called a risk factor which serves as a multiplier of the
average risk of dying within 10 years for each major cause of
death to which the behavior relates (e.g., a two pack/day
smoking habit doubles the average risk of dying from lung
cancer in a 45-year old client). These average risks, present-
ed as the number of deaths among 100,000 people, are
calculated from national mortality statistics and organized
by cause of death (usually the 10 leading causes plus an
"other" category) for groups defined by age in five-year
bands, race as Black or White, and sex.
When there are multiple risk factors for the same cause
of death, their respective numerical values are combined by
a simple formula to yield a composite risk factor which
serves as the multiplier of the average risk of dying for that
cause of death. Multiplying the composite risk factor times
the average risk of dying gives a risk projection which could
be higher or lower than the average risk, depending on the
client's health characteristics. These risk projections are
carried out for each of the ten leading causes of death and
summed with average risk for "other causes" to arrive at a
total projected risk of death. The result is contrasted with the
average total risk. The comparison is usually expressed in
terms of life expectancy or risk age, the latter being the age
of an average person who has the same total risk of death.
Recalculation of the total mortality risk using new risk
factors based on maximal improvements in health-related
behaviors produces a new result, called the achievable or
compliance age.
Nearly every step in this sequence has been criticized
and found to be wanting in terms of its effect on the accuracy
of the prediction that results.6-9 But arithmetic precision is
not of primary importance to the objectives ofHHA/HRA or
HP/DP in general. Much more important considerations are
the scientific validity, credibility, and value of the message
received by the client. In these respects, most HHA/HRA
programs have had to overreach the extent of existing
scientific knowledge in order to accomplish their aim of a
comprehensive risk projection although the projections ap-
pear reasonably accurate. There are, however, several areas
of concern.
First, the health characteristics measured and analyzed
in the standard HHA/HRA include: a) behaviors for which
the scientific evidence of their predictive importance re-
mains controversial (e.g., exercise habits for death from
coronary heart disease); b) characteristics for which the
scientific evidence that intervention is efficacious remain
controversial (e.g., reductions in cholesterol for death from
coronary heart disease); and c) characteristics about which
the client can do nothing (e.g., family history of breast
cancer).
Second, many of the risk factor values are based on
extrapolations of various kinds from data derived from two
major epidemiologic investigations: the Framingham Heart
Disease Study's0- and the American Cancer Society
Study.'2-'4These studies largely involve middle-aged, mid-
dle-class, White subjects, yet their findings are being used to
predict the risk of Blacks, Hispanics, Native Americans,
teenagers and other dissimilar groups. In a few cases, these
extrapolations produce nonsensical risk factor values.
Third, there may be serious difficulties with the message
generated for the younger client. Since most of the risk
factor values represent extrapolations from studies of older
individuals, many of the estimates may be grossly in error.
Furthermore, the 10-year risk of death rises very slowly
among individuals under the age of 35, so that small changes
in total risk translate into dramatic alterations in risk age.
Given these considerations, plus the frequently noted lack of
salience to young people of their long-term mortality pros-
pects, the use of the standard HHA/HRA among young
people is in our view highly questionable.
Fourth, the specification and quantification of risk fac-
tors for some causes of death (e.g., homicide and suicide)
cannot be substantiated, given the scarcity of epidemiologic
studies in these areas.
2. How do programs measure individual health charac-
teristics and to what extent do problems in measurement
influence the acceptability and utility ofHHAIHRA?
The manner in which the client's health characteristics
are measured and recorded by HHA/HRA programs varies
widely. In particular, physiologic measurements like blood
pressure are often carried out by minimally trained person-
nel, with little consideration given to the accuracy of the
measurement. At the one program we visited which had
compared its cholesterol measurements to a standard, labo-
ratory analyses of cholesterol levels were found to be
systematically in error by 30 mg/dl. Perhaps even more
problematic is the practice of asking clients to write in their
own blood pressure or cholesterol levels instead of measur-
ing them; if the client does not write in a value, an average
value is inserted.
Since HHA/HRA programs seldom view the arithmetic
precision of the risk prediction as very important, we heard
few concerns expressed by programs about the quality of
their client data. This lack of concern may not be justified as
recent studies have indicated that clients can give very
different answers to the same HHA/HRA questions when
administered as little as three or four weeks apart, even for
items which could not change. 15-17 For middle-aged and
older clients, an error of 20 per cent or more in the blood
pressure level can create an error of several years in the risk
age computation. Research on the quality of client data and
its effect on the health promotion message has only barely
begun; much more evidence would be needed to answer this
question more definitively.
3. How do programs compute risk and to what extent
do various HHAIHRA approaches yield different risk and
benefit assessments for clients with similar characteristics?
Although many programs have altered the way in which
risk-related information is presented to the client, the actual
computational strategy used to estimate risk and achievable
risk reduction has seen only limited experimentation. Few
vendors or programs have added new health characteristics
to the risk computation although some measure characteris-
tics such as Type A behavior pattern or high density
lipoprotein cholesterol and provide separate feedback con-
cerning those factors. Some programs have developed sim-
plified computational approaches using a limited number of
risk characteristics and providing feedback in the form of a
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"risk score." The risk score, often based on a perfect score
of 100, can free the program from constraints involved in the
mortality prediction framework. These risk score applica-
tions are at the fringe of what is generally regarded as HHA/
HRA. Whether their simplicity of computation and avoid-
ance of risk ages and other life expectancy-oriented feed-
back makes them either more or less efficacious than the
conventional HHA/HRA approach remains to be deter-
mined.
4. What are the settings in which HHAIHRA is being
used and to what extent do the characteristics of the setting
influence the success or failure ofHHAIHRA?
Programs conducted in the workplace constituted near-
ly one-half of the programs identified in our inventory.
Programs offering services to the general public, most com-
monly located in health departments, comprised the next
largest group, followed by programs designed for college
students and the patients of medical care organizations.
Most programs served fewer than 200 clients in 1979 and
nearly one-fourth administered fewer than 50 HHA/HRAs in
that year. Related to the small size of most programs is the
fact that the vast majority first provided services in 1979 or
1980 indicating the recency of the growth in use of HHA/
HRA. Approximately one-half of the identified programs
provided services on company time. The programs which
charged for the administration of HHA/HRA and the provi-
sion of feedback received from $10 to $35 from each client,
exclusive of additional charges for risk reduction services.
The variation in the fees reflects primarily the complexity
and comprehensiveness of the client information gathered,
particularly the extent of laboratory testing done, but also
the elegance of the report give to the client. Such reports
varied from a single page summary to a multi-color personal-
ized book.
Most programs reported providing counseling and risk
reduction services. Counseling ranged from an extensive
personal discussion of the results with a physician, nurse, or
health educator to a large group discussion. Less variation in
risk reduction services was encountered. These services
generally consisted of small group meetings either provided
by or patterned after well-known programs such as Weight
Watchers, Smokenders, and the YMCA exercise pro-
grams.
Although we intentionally chose to visit programs that
were larger, more innovative, and better evaluated than
most of the programs in the inventory, we nevertheless
encountered wide and important variation in the reasons for
using HHA/HRA and in what it was hoped the technique
would accomplish. The often differing conceptions of HHA/
HRA as expressed by the sponsoring agencies and by the
programs ranged from the view of HHA/HRA as a conve-
nient and attractive tool with which to collect client data or
attract attention to the view of HHA/HRA as a powerful
motivational stimulus for health behavior change leading to
reduction in illness and health care costs. Several industry
managers related their interest in HHA/HRA to their con-
cerns about the cost of health care benefits and indicated
that their continued interest would be dependent upon the
effect of HHA/HRA in reducing health insurance claims.
Definitive evidence supporting HHA/HRA success in
changing behaviors or improving health is currently unavail-
able. Programs' success in establishing themselves as mean-
ingful and stable parts of their sponsoring institutions varied.
Factors associated with this sort of success related principal-
ly to the depth of commitment of the sponsoring institution
to promote health-related behavior change among its work-
ers, students, or clients. Our impression is that programs
integrated into an ongoing health or medical service, such as
a medical practice or an employee health or assistance
service, seemed to be the most stable and efficient. Whether
these integral programs produce the greatest positive impact
on clients remains to be demonstrated.
5. What is the evidence supporting a positive effect of
HHAIHRA on participation, knowledge, health-related be-
haviors, morbidity, and mortality?
The enthusiasm for HHA/HRA has been fueled by
anecdotal reports of its effectiveness in increasing participa-
tion in health promotion programs and in motivating behav-
ioral change. Several uncontrolled studies have strengthened
the belief in the technique's effectiveness. Methodologic
problems in studying behavioral change-volunteer bias,
secular change in the public at large, the absence of a
comparison group, and measurement unreliability-severely
limit the scientific validity of these studies. Of three random-
ized controlled studies that have been reported, one found
no impact on attitudes toward disease susceptibility,'8and a
second found no impact on health-related behaviors.'9
The third, and most elaborate, found numerous behav-
ior changes in the HHA/HRA groups compared to the
control group20 but its findings can be viewed only as
suggestive. In this experiment, Lauzon randomly allocated
346 Canadian government workers to three groups: an
"attention control group" not receiving HHAIHRA, a group
receiving only HHA/HRA results and interpretation, and a
group receiving HHA/HRA and personal health counseling.
Follow-up information was obtained three months after
intervention regarding 11 dependent variables including ap-
praised age, blood pressure, several health related behav-
iors, and anxiety levels. The multiple outcomes each were
examined within eight age-sex-risk subgroups and any p-
value less than .05 labeled as "significant." The multiple
comparisons yielded several apparently positive effects of
HHA/HRA but these were generally small and inconsistent-
ly distributed among the subgroups.
Effects on knowledge, although more easily studied,
have received little attention. Several well-designed con-
trolled trials will soon provide better evidence in the area of
health knowledge and behaviors. Morbidity and mortality
are unlikely to show an influence in the short duration of any
studies underway or planned.
6. What is the evidence of physicallpsychological risk
associated with HHAIHRA?
Risk to clients has received little systematic attention
and, in our experience, is not viewed as a significant
possibility by most workers in the field. One study found no
difference in state or trait anxiety scores between groups that
received HHA/HRA feedback and a group that did not.20
However, we did hear anecdotal reports of depressive
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responses to life expectancy predictions among older clients.
Many possible adverse effects, such as anxiety, depression,
hypochondriasis, unnecessary medical expenses, and confu-
sion or even harm from misinformation, could result from
health promotion programs including those using HHA/
HRA. Overemphasis on personal health habits and the
responsibility of the individual may foster a compulsive and
distorted understanding of health and disease, leading to
guilt, intolerance, and mistakes. Investigation of possible
risks from programs aimed at overall life-style change should
receive serious consideration, regardless of whether they
employ HHA/HRA. We view this as an important issue to be
considered in planning future research.
7. What is the acceptability, validity, and efficacy of
HHAIHRA for less-advantaged social groups?
HHA/HRA has been characterized as being most rele-
vant for White middle-class clients. Our review and site
visits found little to dispute this characterization. Epidemio-
logic data on most risk factor-disease relationships on non-
Whites are sparse, so validity is uncertain. The question of
whether HHA/HRA computations for Black clients should
be based on Black mortality statistics remains unsettled in
our view. The most consequential effect of using race-
specific mortality rates as contrasted with total mortality
rates is to highlight the high risk of homicide among younger
Blacks. For example, the fact that homicide is the major
cause of death among Black men between ages 20-39 would
be obscured through the use of total mortality statistics.
Whether emphasizing the risk among Blacks of death from
homicide would enhance or diminish the acceptability or
effectiveness of HHA/HRA among Black clients requires
further study.
HHA/HRA's highly quantitative presentation generally
demands a higher-than-average educational background.
The focus on modification of personal behaviors to increase
longevity appears to have a weaker impact for persons for
whom securing current necessities dominates their attention.
Presumably for this and other reasons, participation by less-
advantaged groups has been low in programs that have
attempted to recruit clients from among these groups. There
is no evidence as to the impact of HHA/HRA or related
techniques on such clients, which we view as a major
research need.
8. What are the major areas regarding HHAIHRA that
are in need offurther research?
We recommend increased research activity in the fol-
lowing areas:
* The determinants of health-related behaviors and the
factors that sustain them,
* Strategies for motivating and supporting health-relat-
ed behavior change with special attention to those that take a
positive orientation,
* The attitudes and beliefs of minority groups toward
HP/DP and the barriers to their participation,
* The role and impact of the medical practitioner in HP/
DP,
* The possible harmful effects of HP/DP interventions
particularly those using personalized risk information,
* The source of errors in data collection and their
impact on the message given to clients of HHA/HRA pro-
grams,
* The perceptions and knowledge ofHHA/HRA clients
regarding the information collected from them and returned
to them, and
* The efficacy of HHA/HRA, as compared to other
approaches, in stimulating participation in risk reduction
activities and producing health-related behavior change.
Conclusion
Health hazard/health risk appraisal (HHA/HRA) is an
appealing technique which may have potential as a tool in
health promotion/disease prevention (HP/DP) efforts. Its
attraction derives probably as much from the lack of pack-
aged options for individuals working in HP/DP as from
demonstrable effects of the HHA/HRA process. We feel that
the current degree of attention given specifically to HHA/
HRA may be excessive and that such a concentration of
interest risks missing the forest (HP/DP) for the tree (HHA/
HRA).
HP/DP is an area which requires innovative program-
ming and careful evaluation of results. HHA/HRA is but one
approach and should be viewed with care and circumspec-
tion-care to ensure that assumptions are tested, and cir-
cumspection in view of the paucity of current evidence
regarding its effectiveness. Caution is also indicated since
HHA/HRA programs, like other HP/DP efforts aimed at
modifying personal behaviors, have the potential for the
promulgation of life-styles possibly inadequately supported
by existing scientific evidence and/or inconsistent with val-
ues and traditions of specific population groups. There are
also concerns that such programs may constitute "blaming
the victim" or may pay insufficient regard to the influence of
environmental and social factors on health and health-
related behaviors.
Programs attempting to change behaviors and improve
health have been searching for effective tools. Our evalua-
tion of the current state of the art in HHA/HRA suggests that
there is no reason to abandon that search.
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1982 Cornell Health Executives Development Program
Applications are now being accepted for the silver anniversary session of the Health Executives
Development Program, to be offered on the Ithaca campus from June 14-24, 1982. Approximately 30
speakers, all professionals in the health care field, will discuss the latest trends and issues in health
policy, planning, regulation, and management. A variety of points of view are presented to stimulate
each participant to seek fresh approaches to health services problems and to lay the groundwork for
continuing self-development.
Participants will include professionals from hospital administration, public health, health planning
and regulatory agencies, clinical and medical administration, and executives of other health care
organizations from the US, Canada, and overseas.
For further information and applications, contact Health Executives Development Program,
Graduate School of Business and Public Administration, Malott Hall, Cornell University, Ithaca, NY,
14853, 607/256-4686.
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